1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Liver conditions
  5. Chronic liver disease

Semaglutide for treating non-alcoholic steatohepatitis with significant liver fibrosis ID6458

Awaiting development [GID-TA11477] Expected publication date: TBC

  • Project information
  • Project documents

NIHRIO BN: 13408-Semaglutide-for-Non-Alcoholic-Steatohepatitis-V1.0-OCT2023-NON-CONF.pdf (nihr.ac.uk)